Fash2021's Profile Page - moomoo Community

Fash2021

ID: 70683611

No profile added yet

Following

Followers

Visitors

Recommended Users

SpyderCall

Keen on information sharing

joined discussion·Apr 30, 2022 04:24

Part Two: How do I use the RSI to trade?

USD 20 Stock Cash Coupon Giveaways
Post your learning results by taping the discussion: How does RSI tell whether your stock is overbought or oversold?
Hi mooers!
Have you used the RSI to help you decide whether to buy or sell a stock? If you have, you may find the RSI doesn't work sometimes. Even if it falls below 30, it doesn't go up at all. Instead, the price keeps falling.
Therefore, it's better to adopt the RSI indicator with other indicators to...

TA Challenge: How does RSI tell whether a stock is overbought or oversold?

Fash2021 liked

Analysts Notebook

wrote a column·May 2, 2022 06:06

ColumnsTop upgrades and downgrades on 5/2

Upgrades
• $Accolade(ACCD.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $6 (from $9)
• $Comerica(CMA.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $94 (from $90)
• $New Oriental(EDU.US)$ : JPMorgan Upgrades to Neutral from Underweight - PT $14 (from $35)
• $EPAM Systems(EPAM.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $348 (from $359)
• $Empire State Realty Trust Inc(ESRT.US)$ : Evercore ISI Upgrades to Outp...

Fash2021 liked

Moomoo Recap US

wrote a column·Aug 19, 2021 10:19

ColumnsTop upgrades and downgrades on 8/19

Thursday, August 19, 2021
By Jimmy

Fash2021

commented on a stock·Aug 19, 2021 08:00

$PetVivo(PETV.US)$

Translated

Fash2021

wrote a post·Aug 19, 2021 07:57

PETV

In the Opportunity Research report, analyst Rob Goldman discusses how PetVivo could emerge as the standard of care in the multi-billion dollar osteoarthritis market for companion animals as well as the fastest growing company in the animal health sector, overall.Long History of Success, Strong Safety ProfileGoldman noted, "PetVivo Holdings is well-positioned to emerge as the standard of care for the treatment of osteoarthritis in dogs and horses and other companion animals. This unmet need represents an estimated $4.4B combined annual market. PETV's flagship platform has a long history of success, addresses the underlying cause of OA, and has a strong safety profile. Given its efficacy, affordability, and the emergence of new revenue streams for veterinarians, PETV offers a compelling therapy."
...